Table 1.

Baseline Characteristics of Study Participants

	Total cohort (n=62)	Treatment-naïve cohort (n=25)
Age (years)	61 [41–60]	55 [43–59]
Female sex	37 (59.7)	16 (64.0)
Height (m)	1.64 [1.55–168.8]	1.57 [1.54–1.66]
Body weight (kg)	64 [53–74]	62 [52–77]
WHO functional class
I	6 (9.7)	1 (4.0)
II	28 (45.2)	9 (36.0)
III	25 (40.3)	12 (48.0)
IV	3 (4.8)	3 (12.0)
BNP (pg/mL)	60 [21–209]	79 [37–347]
Bilirubin (mg/dL)	1.4 [1.0–2.2]	2.1 [1.4–2.8]
Creatinine (mg/dL)	0.70 [0.63–0.94]	0.69 [0.62–0.75]
Uric acid (mg/dL)	5.7 [4.6–7.2]	6.9 [4.3–7.6]
6MWD (m)	380 [308–455]	350 [298–392]

Values are expressed as the median [interquartile range] or n (%). 6MWD, 6-min walk distance; BNP, B-type natriuretic peptide; WHO, World Health Organization.